FDA Presents Webinar on Draft Guidance on Vaginal Microbicides for the Prevention of HIV Infection

“On Tuesday, January 22, 2013, from 2:00 - 3:00PM (ET), FDA will present a webinar to discuss the recently published draft guidance for industry entitled, 'FDA Guidance for Industry Webinar on Draft Guidance Vaginal Microbicides: Development for the Prevention of HIV Infection' … “This webinar will focus on select sections of the guidance including:  Clinical considerations in early phase development key safety considerations including safety data in specific populations such as pregnant women and adolescents, Phase 3 trial design issues,and risk-benefit considerations. “Other topics that will be covered in brief include non-clinical development considerations and approaches to combination product development. The webinar is intended to provide developers, industry, and academia an overview of key issues discussed in this draft FDA guidance.”   Visit the FDA website for more information and for instructions on how to access the webinar.